$STE
STERIS plc Stock $ste

$ste Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000175789820000022 Filed on August 07, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q2
Revenue	$668.9M	$823.0M	$696.8M
YoY Change	-4.0%	7.13%	9.09%
Cost Of Revenue	$381.5M	$459.9M	$389.9M
YoY Change	-2.15%	6.09%	5.47%
Gross Profit	$287.4M	$363.1M	$306.9M
YoY Change	-6.36%	8.48%	14.06%
Gross Profit Margin	42.96%	44.12%	44.04%
Selling, General & Admin	$155.2M	$189.1M	$178.8M
YoY Change	-13.21%	9.24%	12.86%
% of Gross Profit	53.99%	52.08%	58.26%
Research & Development	$16.23M	$17.20M	$15.59M
YoY Change	4.15%	8.18%	-3.91%
% of Gross Profit	5.65%	4.74%	5.08%
Depreciation & Amortization	$48.95M	$50.90M	$47.10M
YoY Change	3.93%	1.39%	0.53%
% of Gross Profit	17.03%	14.02%	15.35%
Operating Expenses	$171.6M	$206.3M	$195.8M
YoY Change	-12.36%	9.1%	12.1%
Operating Profit	$115.8M	$156.8M	$110.1M
YoY Change	5.2%	7.67%	16.59%
Interest Expense	$9.492M	-$9.800M	$10.45M
YoY Change	-9.12%	30.67%	-11.03%
% of Operating Profit	8.2%	-6.25%	9.49%
Other Income/Expense, Net	-$7.203M		-$10.68M
YoY Change	-32.54%		-6.11%
Pretax Income	$108.6M	$148.1M	$99.41M
YoY Change	9.26%	11.35%	19.7%
Income Tax	$19.08M	$24.80M	$14.63M
% Of Pretax Income	17.57%	16.75%	14.72%
Net Earnings	$89.60M	$122.6M	$85.37M
YoY Change	4.95%	12.73%	21.97%
Net Earnings / Revenue	13.39%	14.9%	12.25%
Basic Earnings Per Share	$1.05	$1.44	$1.01
Diluted Earnings Per Share	$1.05	$1.43	$1.00
COMMON SHARES
Basic Shares Outstanding	84.96M shares	84.81M shares	84.64M shares
Diluted Shares Outstanding	85.68M shares		85.57M shares

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$255.6M	$319.6M	$238.1M
YoY Change	7.35%	44.88%	8.97%
Cash & Equivalents	$255.6M	$319.6M	$238.1M
Short-Term Investments
Other Short-Term Assets	$61.40M	$54.40M	$63.00M
YoY Change	-2.54%	-9.48%	14.55%
Inventory	$277.0M	$263.5M	$233.6M
Prepaid Expenses
Receivables	$503.2M	$586.5M	$509.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.097B	$1.224B	$1.044B
YoY Change	5.06%	16.16%	5.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.148B	$1.112B	$1.054B
YoY Change	8.9%	7.78%	7.11%
Goodwill	$2.372B	$2.356B	$2.347B
YoY Change	1.04%	1.43%
Intangibles	$551.5M	$565.5M	$602.2M
YoY Change	-8.41%	-6.47%
Long-Term Investments
YoY Change
Other Assets	$51.97M	$51.58M	$59.20M
YoY Change	-12.21%	-14.33%	27.85%
Total Long-Term Assets	$4.267B	$4.217B	$4.185B
YoY Change	1.94%	4.91%	3.02%
TOTAL ASSETS
Total Short-Term Assets	$1.097B	$1.224B	$1.044B
Total Long-Term Assets	$4.267B	$4.217B	$4.185B
Total Assets	$5.364B	$5.441B	$5.230B
YoY Change	2.57%	7.25%	3.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$133.5M	$149.3M	$135.5M
YoY Change	-1.44%	-2.34%	3.66%
Accrued Expenses	$180.2M	$192.2M	$182.8M
YoY Change	-1.43%	2.35%	37.45%
Deferred Revenue
YoY Change
Short-Term Debt	$35.00M	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$479.5M	$503.6M	$432.8M
YoY Change	10.81%	8.26%	15.78%
LONG-TERM LIABILITIES
Long-Term Debt	$1.022B	$1.151B	$1.210B
YoY Change	-15.52%	-2.76%	-8.34%
Other Long-Term Liabilities	$86.39M	$90.35M	$85.07M
YoY Change	1.55%	2.89%	-18.12%
Total Long-Term Liabilities	$1.109B	$1.241B	$1.295B
YoY Change	-14.4%	-2.37%	-9.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$479.5M	$503.6M	$432.8M
Total Long-Term Liabilities	$1.109B	$1.241B	$1.295B
Total Liabilities	$1.874B	$2.023B	$1.985B
YoY Change	-5.57%	7.17%	1.03%
SHAREHOLDERS EQUITY
Retained Earnings	$1.700B	$1.659B	$1.397B
YoY Change	21.65%	23.87%
Common Stock	$1.983B	$1.982B	$1.996B
YoY Change	-0.67%	-0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.475B	$3.405B	$3.237B
YoY Change
Total Liabilities & Shareholders Equity	$5.364B	$5.441B	$5.230B
YoY Change	2.57%	7.25%	3.52%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q2
OPERATING ACTIVITIES
Net Income	$89.60M	$122.6M	$85.37M
YoY Change	4.95%	12.73%	21.97%
Depreciation, Depletion And Amortization	$48.95M	$50.90M	$47.10M
YoY Change	3.93%	1.39%	0.53%
Cash From Operating Activities	$134.1M	$199.3M	$109.3M
YoY Change	22.67%	11.4%	8.49%
INVESTING ACTIVITIES
Capital Expenditures	$66.86M	-$60.90M	$49.79M
YoY Change	34.28%	-20.39%	79.59%
Acquisitions	$0.00		$34.97M
YoY Change	-100.0%
Other Investing Activities	$100.0K	$1.100M	$0.00
YoY Change		-60.71%	-100.0%
Cash From Investing Activities	-$66.72M	-$59.70M	-$84.31M
YoY Change	-20.86%	-18.89%	141.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$14.30M		$14.89M
YoY Change	-3.96%		-56.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$134.0M	-9.200M	-$7.607M
YoY Change	1661.54%	-91.71%	-80.6%
NET CHANGE
Cash From Operating Activities	$134.1M	199.3M	$109.3M
Cash From Investing Activities	-$66.72M	-59.70M	-$84.31M
Cash From Financing Activities	-$134.0M	-9.200M	-$7.607M
Net Change In Cash	-$63.95M	130.4M	$17.43M
YoY Change	-466.83%	-2387.72%	-34.7%
FREE CASH FLOW
Cash From Operating Activities	$134.1M	$199.3M	$109.3M
Capital Expenditures	$66.86M	-$60.90M	$49.79M
Free Cash Flow	$67.26M	$260.2M	$59.54M
YoY Change	12.96%	1.88%	-18.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	128261000	USD
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	500000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	500000000	shares
CY2020Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	ste	Aggregate Amountof Shares Authorized AggregateAmountofSharesAuthorized	500000000	USD
CY2020Q2	ste	Aggregate Amountof Shares Authorized AggregateAmountofSharesAuthorized	500000000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12051000	USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10839000	USD
CY2019Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.34
CY2020Q2	dei	Amendment Flag AmendmentFlag	false
CY2020Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2020Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2020Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001757898
CY2020Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.37
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84924000	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85060000	shares
CY2019Q2	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax	170000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax	174000	USD
CY2020Q2	dei	Document Type DocumentType	10-Q
CY2020Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q2	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
CY2020Q2	dei	Entity File Number EntityFileNumber	001-38848
CY2020Q2	dei	Entity Registrant Name EntityRegistrantName	STERIS plc
CY2020Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
CY2020Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1455064
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	503172000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	586481000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	276970000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	248259000	USD
CY2020Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	61359000	USD
CY2020Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	54430000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	1097128000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	1208751000	USD
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85053103	shares
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1148052000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1111855000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	143463000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	255627000	USD
CY2020Q2	dei	Security12b Title Security12bTitle	Ordinary Shares, $0.001 par value
CY2020Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	255627000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	319581000	USD
CY2020Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	70 Sir John Rogerson's Quay,
CY2020Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 2,
CY2020Q2	dei	Entity Address Country EntityAddressCountry	IE
CY2020Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D02 R296
CY2020Q2	dei	City Area Code CityAreaCode	353
CY2020Q2	dei	Local Phone Number LocalPhoneNumber	1 232 2000
CY2020Q2	dei	Trading Symbol TradingSymbol	STE
CY2020Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q2	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	131837000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	2371789000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	2356085000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	551526000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	565473000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51969000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51581000	USD
CY2020Q2	us-gaap	Assets Assets	5363927000	USD
CY2020Q1	us-gaap	Assets Assets	5425582000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	133532000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	149341000	USD
CY2020Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	28205000	USD
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	14013000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	82039000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	128261000	USD
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	35000000	USD
CY2020Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	20575000	USD
CY2020Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	19809000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	180198000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	192183000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	479549000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	503607000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1022156000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1150521000	USD
CY2020Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	160972000	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	1983047000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	160270000	USD
CY2020Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	125151000	USD
CY2020Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	114114000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	86386000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	90346000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	1874214000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	2018858000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	1982164000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1699971000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1647175000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-208354000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-235463000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	3474664000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3393876000	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	15049000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	12848000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3489713000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3406724000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5363927000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5425582000	USD
CY2020Q2	us-gaap	Revenues Revenues	668932000	USD
CY2019Q2	us-gaap	Revenues Revenues	696803000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	383364000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	390960000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	285568000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	305843000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	155170000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	178781000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16231000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15585000	USD
CY2020Q2	us-gaap	Restructuring Costs RestructuringCosts	166000	USD
CY2019Q2	us-gaap	Restructuring Costs RestructuringCosts	1389000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	171567000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	195755000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	114001000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	110088000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	9492000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	10445000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2289000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-233000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7203000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10678000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	106798000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99410000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18674000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14633000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	88124000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	84777000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-66000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	187000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	88190000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	84590000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.04
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.37
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2020Q2	us-gaap	Profit Loss ProfitLoss	88124000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	84777000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-66000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	187000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	88190000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	84590000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-510000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-505000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	27619000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	3439000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	27109000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2934000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	115299000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	87524000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	88124000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	84777000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48954000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47102000	USD
CY2020Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-189000	USD
CY2019Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-612000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5962000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5537000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17011000	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-237000	USD
CY2019Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-61000	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-10000	USD
CY2019Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2426000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17276000	USD
CY2020Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6842000	USD
CY2020Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-49728000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57620000	USD
CY2020Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	27015000	USD
CY2019Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24622000	USD
CY2020Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6729000	USD
CY2019Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2480000	USD
CY2019Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-596000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84665000	USD
CY2019Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-43792000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	134122000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	109337000	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66861000	USD
CY2019Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49794000	USD
CY2020Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	137000	USD
CY2019Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	18000	USD
CY2020Q2	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2019Q2	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	439000	USD
CY2020Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	34970000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-66724000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84307000	USD
CY2020Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-95837000	USD
CY2019Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	27861000	USD
CY2020Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1206000	USD
CY2020Q2	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	21000	USD
CY2019Q2	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	452000	USD
CY2020Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14296000	USD
CY2019Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14886000	USD
CY2020Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	31471000	USD
CY2019Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28823000	USD
CY2020Q2	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2258000	USD
CY2019Q2	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2020Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5367000	USD
CY2019Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	9899000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-134000000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7607000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220633000	USD
CY2020Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2648000	USD
CY2019Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	11000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63954000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17434000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	319581000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	88124000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	27109000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238067000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3406724000	USD
CY2020Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14296000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11256000	USD
CY2020Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31471000	USD
CY2020Q2	ste	Contributionsfromnoncontrollinginterest Contributionsfromnoncontrollinginterest	-2258000	USD
CY2020Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	9000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3489713000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3185798000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	84777000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2934000	USD
CY2019Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14886000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15275000	USD
CY2019Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28823000	USD
CY2019Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-73000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3245002000	USD
CY2020Q2	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations and Summary of Significant Accounting Policies<div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Operations</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">STERIS plc is a leading provider of infection prevention and other procedural products and services. Our MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe. We offer our Customers a unique mix of innovative consumable products, such as detergents, gastrointestinal ("GI") endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory testing services, on-site and off-site reprocessing, and capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room (“OR”) integration.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our fiscal year ends on March 31. References in this Quarterly Report to a particular “year” or “year-end” mean our fiscal year. The significant accounting policies applied in preparing the accompanying consolidated financial statements of the Company are summarized below:</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interim Financial Statements</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We prepared the accompanying unaudited consolidated financial statements of the Company according to accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. This means that they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Our unaudited interim consolidated financial statements contain all material adjustments (including normal recurring accruals and adjustments) management believes are necessary to fairly state our financial condition, results of operations, and cash flows for the periods presented.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These interim consolidated financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> dated </span><span style="font-family:inherit;font-size:10pt;">May 29, 2020</span><span style="font-family:inherit;font-size:10pt;">. The Consolidated Balance Sheet at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use the consolidation method to report our investment in our subsidiaries. Therefore, the accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. We eliminate inter-company accounts and transactions when we consolidate these accounts. Investments in equity of unconsolidated affiliates, over which the Company has significant influence, but not control, over the financial and operating polices, are accounted for primarily using the equity method. These investments are immaterial to the Company's Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available. This means that operating results for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> month period ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2020</span><span style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of results that may be expected for future quarters or for the full fiscal year ending March 31, 2021.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Revenue Recognition and Associated Liabilities</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted Accounting Standards Update ("ASU") 2014-09 “Revenue from Contracts with Customers” and the subsequently issued amendments on April 1, 2018. At the time of adoption, certain of our capital equipment contracts were comprised of a single integrated performance obligation, which resulted in the deferral of the corresponding capital equipment revenue and cost of revenues until installation was complete. Since the adoption of the standard, there have been changes made in our selling philosophy, product architecture, and manufacturing processes with respect to this product line, that impact whether the promises to transfer the individual goods or services to the Customer are separately identifiable from other promises in the contract. After review of these changes, we have concluded that these contracts consist of multiple performance obligations that are capable of being distinct and meet the criteria for revenue to be recognized when the Customer obtains </span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">control of the asset, which is upon delivery of each performance obligation. Revenues and costs of revenues related to these contracts totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$14,609</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$7,560</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, that had previously been deferred were recognized in our fiscal 2021 first quarter.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized when obligations under the terms of the contract are satisfied and control of the promised products or services have transferred to the Customer. Revenues are measured at the amount of consideration that we expect to be paid in exchange for the products or services. Product revenue is recognized when control passes to the Customer, which is generally based on contract or shipping terms. Service revenue is recognized when the Customer benefits from the service, which occurs either upon completion of the service or as it is provided to the Customer. Our Customers include end users as well as dealers and distributors who market and sell our products. Our revenue is not contingent upon resale by the dealer or distributor, and we have no further obligations related to bringing about resale. Our standard return and restocking fee policies are applied to sales of products. Shipping and handling costs charged to Customers are included in Product revenues. The associated expenses are treated as fulfillment costs and are included in Cost of revenues. Revenues are reported net of sales and value-added taxes collected from Customers.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have individual Customer contracts that offer discounted pricing. Dealers and distributors may be offered sales incentives in the form of rebates. We reduce revenue for discounts and estimated returns, rebates, and other similar allowances in the same period the related revenues are recorded. The reduction in revenue for these items is estimated based on historical experience and trend analysis to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded gross on the Consolidated Balance Sheets.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In transactions that contain multiple performance obligations, such as when products, maintenance services, and other services are combined, we recognize revenue as each product is delivered or service is provided to the Customer. We allocate the total arrangement consideration to each performance obligation based on its relative standalone selling price, which is the price for the product or service when it is sold separately.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payment terms vary by the type and location of the Customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. We do not evaluate whether the selling price contains a financing component for contracts that have a duration of less than one year.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We do not capitalize sales commissions as substantially all of our sales commission programs have an amortization period of one year or less.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain costs to fulfill a contract are capitalized and amortized over the term of the contract if they are recoverable, directly related to a contract and generate resources that we will use to fulfill the contract in the future. At June 30, 2020, assets related to costs to fulfill a contract were not material to our Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Refer to Note 9, titled "Business Segment Information" for disaggregation of revenue.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Product Revenue</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer or Group Purchasing Organization ("GPO") agreement.</span><span style="font-family:inherit;font-size:10pt;color:#ff0000;"> </span><span style="font-family:inherit;font-size:10pt;">We recognize revenue for sales of product when control passes to the Customer, which generally occurs either when the products are shipped or when they are received by the Customer. Revenue related to capital equipment products is deferred until installation is complete if the capital equipment and installation are highly integrated and form a single performance obligation.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Service Revenue</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Within our Healthcare and Life Sciences segments, service revenues consist of revenue generated from parts and labor associated with the maintenance, repair and installation of capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer, or Group Purchasing Organization ("GPO") agreement. For maintenance, repair and installation of capital equipment, revenue is recognized upon completion of the service. Healthcare service revenues also include outsourced reprocessing services and instrument repairs. Contracts for outsourced reprocessing services are primarily based on an agreement with a Customer, ranging in length from several months to 15 years. Outsourced reprocessing services revenue is recognized ratably over the contract term using a time-based input measure, adjusted for volume and other performance metrics, to the extent that it is probable that a significant reversal of revenue will not occur. Contracts for instrument repairs are primarily based on a Customer’s purchase order, and the associated revenue is recognized upon completion of the repair. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and repair our products over the duration of the contract. Generally, these contract terms are cancelable without penalty and range from one to five years. Amounts received under these Customer contracts are initially recorded as a service liability and are recognized as service revenue ratably over the contract term using a time-based input measure. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Within our Applied Sterilization Technologies segment, service revenues include contract sterilization and laboratory services. Sales contracts for contract sterilization and laboratory services are primarily based on a Customer’s purchase order and associated Customer agreement and revenues are generally recognized upon completion of the service.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Contract Liabilities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments received from Customers are based on invoices or billing schedules as established in contracts with Customers. Deferred revenue is recorded when payment is received in advance of performance under the contract. Deferred revenue is recognized as revenue upon completion of the performance obligation, which generally occurs within one year. During the first three months of fiscal 2021, </span><span style="font-family:inherit;font-size:10pt;"><span>$30,804</span></span><span style="font-family:inherit;font-size:10pt;"> of the March 31, 2020 deferred revenue balance was recorded as revenue. During the first three months of fiscal 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>$39,484</span></span><span style="font-family:inherit;font-size:10pt;"> of the March 31, 2019 deferred revenue balance was recorded as revenue.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Refer to Note 6, titled "Additional Consolidated Balance Sheet Information" for Deferred revenue balances.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Service Liabilities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments received in advance of performance for cancelable preventive maintenance and separately priced extended warranty contracts are recorded as service liabilities. Service liabilities are recognized as revenue as performance is rendered under the contract. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Refer to Note 6, titled "Additional Consolidated Balance Sheet Information" for Service liability balances.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Remaining Performance Obligations</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining performance obligations reflect only the performance obligations related to agreements for which we have a firm commitment from a Customer to purchase and exclude variable consideration related to unsatisfied performance obligations. With regard to products, these remaining performance obligations include capital equipment and consumable orders which have not shipped. With regard to service, these remaining performance obligations primarily include installation, certification, and outsourced reprocessing services. As of June 30, 2020, the transaction price allocated to remaining performance obligations was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$930,000</span></span><span style="font-family:inherit;font-size:10pt;">. We expect to recognize approximately </span><span style="font-family:inherit;font-size:10pt;"><span>48%</span></span><span style="font-family:inherit;font-size:10pt;"> of the transaction price within one year and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>46%</span></span><span style="font-family:inherit;font-size:10pt;"> beyond one year. The remainder has yet to be scheduled for delivery. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Issued Accounting Standards Impacting the Company</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recently Issued Accounting Standards Impacting the Company are presented in the following table:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:15%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:38%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Standard</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Date of Issuance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Date of Adoption</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Effect on the financial statements or other significant matters</span></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Standards that have been adopted in fiscal 2021</span></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASU 2016-13, "Measurement of Credit Losses on Financial Instruments"</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">June 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The standard required a financial asset (or group of financial assets) measured at amortized cost to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. The standard was effective for annual periods beginning after December 15, 2019. </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First Quarter Fiscal 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted this standard effective April 1, 2020 with no material impact to our consolidated financial statements.</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:15%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:38%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASU 2018-13 "Fair Value Measurement (Topic 820) Disclosure Framework- Changes to Disclosure Requirements for Fair Value Measurement”</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The standard modified the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy. The standard was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First Quarter Fiscal 2021</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted this standard effective April 1, 2020 with no material impact on our consolidated financial statements as it modifies disclosure requirements only.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASU 2018-14 "Compensation- Retirement Benefits - Defined Benefit Plans- General Topic (715-20): Disclosure Framework- Changes to the Disclosure Requirements for Defined Benefit Plans"</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The standard modified the disclosure requirements by adding, removing, and modifying certain required disclosures for employers that sponsor defined benefit pension or other post-retirement benefit plans. The standard also clarified disclosure requirements for defined benefit pension plans relating to the projected benefit obligation and accumulated benefit obligation. The standard was effective for fiscal years ending after December 15, 2019.</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First Quarter Fiscal 2021</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted this standard effective April 1, 2020 with no material impact on our consolidated financial statements as it modifies disclosure requirements only.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASU 2018-15 "Intangibles- Goodwill and Other- Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract"</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">August 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The standard aligned the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">obtain internal-use software. The standard was effective for fiscal years beginning after December 15, 2019.</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">First Quarter Fiscal 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted this standard on April 1, 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Standards that have not yet been adopted</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ASU 2019-12 "Income Taxes (Topic 740)"</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The standard provides final guidance that simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in ASC 740 related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The guidance simplifies accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for fiscal years beginning after December 15, 2020 and early adoption is permitted.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">N/A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are in the process of evaluating the impact that the standard will have on our consolidated financial statements.</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A detailed description of our significant and critical accounting policies, estimates, and assumptions is included in our consolidated financial statements included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> dated </span><span style="font-family:inherit;font-size:10pt;">May 29, 2020</span><span style="font-family:inherit;font-size:10pt;">. Our significant and critical accounting policies, estimates, and assumptions have not changed materially from </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">.</span></div>
CY2020Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available. This means that operating results for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> month period ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2020</span><span style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of results that may be expected for future quarters or for the full fiscal year ending March 31, 2021.</span></div>
CY2020Q2	ste	Deferred Revenues Amountrecognizedinperiodfromcertaincapitalcontracts DeferredRevenuesAmountrecognizedinperiodfromcertaincapitalcontracts	14609000	USD
CY2020Q2	ste	Deferred Costof Revenues Amountrecognizedinperiodfromcertaincapitalcontracts DeferredCostofRevenuesAmountrecognizedinperiodfromcertaincapitalcontracts	7560000	USD
CY2020Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	30804000	USD
CY2019Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	39484000	USD
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	930000000	USD
CY2020Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2671000	USD
CY2020Q2	us-gaap	Restructuring And Related Cost Expected Number Of Positions Eliminated RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated	200
CY2020Q2	ste	Restructuringexpenseincurredsince Planinception RestructuringexpenseincurredsincePlaninception	44017000	USD
CY2020Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	104557000	USD
CY2020Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	94321000	USD
CY2020Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	40833000	USD
CY2020Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	35643000	USD
CY2020Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	167277000	USD
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	151381000	USD
CY2020Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	18753000	USD
CY2020Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	16937000	USD
CY2020Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	16944000	USD
CY2020Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	16149000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	276970000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	248259000	USD
CY2020Q2	us-gaap	Deferred Revenue DeferredRevenue	39975000	USD
CY2020Q1	us-gaap	Deferred Revenue DeferredRevenue	53299000	USD
CY2020Q2	us-gaap	Land Land	66390000	USD
CY2020Q1	us-gaap	Land Land	65994000	USD
CY2020Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	534095000	USD
CY2020Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	531267000	USD
CY2020Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	692188000	USD
CY2020Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	682488000	USD
CY2020Q2	ste	Capitalized Computer Hardware Software Gross CapitalizedComputerHardwareSoftwareGross	180378000	USD
CY2020Q1	ste	Capitalized Computer Hardware Software Gross CapitalizedComputerHardwareSoftwareGross	181112000	USD
CY2020Q2	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	524356000	USD
CY2020Q1	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	508593000	USD
CY2020Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	198600000	USD
CY2020Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	159731000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2196007000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2129185000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1047955000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1017330000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1148052000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1111855000	USD
CY2020Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	35000000	USD
CY2020Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	0	USD
CY2020Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	35000000	USD
CY2020Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	0	USD
CY2020Q2	us-gaap	Line Of Credit LineOfCredit	180574000	USD
CY2020Q1	us-gaap	Line Of Credit LineOfCredit	275449000	USD
CY2020Q2	us-gaap	Senior Long Term Notes SeniorLongTermNotes	844765000	USD
CY2020Q1	us-gaap	Senior Long Term Notes SeniorLongTermNotes	878409000	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3183000	USD
CY2020Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3337000	USD
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	1022156000	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	1150521000	USD
CY2020Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1057156000	USD
CY2020Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1150521000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	45787000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	42205000	USD
CY2020Q2	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	10899000	USD
CY2020Q1	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	9917000	USD
CY2020Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	12621000	USD
CY2020Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	53041000	USD
CY2020Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	8876000	USD
CY2020Q1	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	19298000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	60107000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	58158000	USD
CY2020Q2	us-gaap	Other Postretirement Benefits Payable Current And Noncurrent OtherPostretirementBenefitsPayableCurrentAndNoncurrent	1488000	USD
CY2020Q1	us-gaap	Other Postretirement Benefits Payable Current And Noncurrent OtherPostretirementBenefitsPayableCurrentAndNoncurrent	1488000	USD
CY2020Q2	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent	2368000	USD
CY2020Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent	2312000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	82039000	USD
CY2020Q2	ste	Serviceliabilities Serviceliabilities	45423000	USD
CY2020Q1	ste	Serviceliabilities Serviceliabilities	47505000	USD
CY2020Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7942000	USD
CY2020Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7342000	USD
CY2020Q2	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	18841000	USD
CY2020Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	15827000	USD
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7002000	USD
CY2020Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7381000	USD
CY2020Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	908000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	180198000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	192183000	USD
CY2020Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	17452000	USD
CY2020Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	17452000	USD
CY2020Q2	us-gaap	Other Postretirement Benefits Payable Noncurrent OtherPostretirementBenefitsPayableNoncurrent	9012000	USD
CY2020Q1	us-gaap	Other Postretirement Benefits Payable Noncurrent OtherPostretirementBenefitsPayableNoncurrent	9880000	USD
CY2020Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	11632000	USD
CY2020Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	10987000	USD
CY2020Q2	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	2371000	USD
CY2020Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	2333000	USD
CY2020Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	11991000	USD
CY2020Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	11959000	USD
CY2020Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	11120000	USD
CY2020Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	9843000	USD
CY2020Q2	ste	Longtermliabilitiesother Longtermliabilitiesother	22808000	USD
CY2020Q1	ste	Longtermliabilitiesother Longtermliabilitiesother	27892000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	86386000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	90346000	USD
CY2019Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.175
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.147
CY2020Q2	ste	Uncertain Tax Liability Resulting From Irs Notice UncertainTaxLiabilityResultingFromIRSNotice	40000000	USD
CY2020Q2	ste	Amortizationandimpairmentofacquiredintangibleassets Amortizationandimpairmentofacquiredintangibleassets	17500000	USD
CY2019Q2	ste	Amortizationandimpairmentofacquiredintangibleassets Amortizationandimpairmentofacquiredintangibleassets	16949000	USD
CY2020Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1286000	USD
CY2019Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1917000	USD
CY2020Q2	ste	Redomiciliationcosts Redomiciliationcosts	170000	USD
CY2019Q2	ste	Redomiciliationcosts Redomiciliationcosts	1770000	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-10000	USD
CY2019Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2426000	USD
CY2020Q2	ste	Amortizationofinventoryandpropertystepuptofairvalue Amortizationofinventoryandpropertystepuptofairvalue	603000	USD
CY2019Q2	ste	Amortizationofinventoryandpropertystepuptofairvalue Amortizationofinventoryandpropertystepuptofairvalue	735000	USD
CY2020Q2	ste	Covid19incrementalcosts COVID19incrementalcosts	8670000	USD
CY2019Q2	ste	Covid19incrementalcosts COVID19incrementalcosts	0	USD
CY2020Q2	us-gaap	Restructuring Charges RestructuringCharges	166000	USD
CY2019Q2	us-gaap	Restructuring Charges RestructuringCharges	2307000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	114001000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	110088000	USD
CY2020Q2	us-gaap	Revenues Revenues	668932000	USD
CY2019Q2	us-gaap	Revenues Revenues	696803000	USD
CY2020Q2	us-gaap	Assets Assets	5363927000	USD
CY2020Q1	us-gaap	Assets Assets	5425582000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84959000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84638000	shares
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	717000	shares
CY2019Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	928000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85676000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85566000	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.2027
CY2020Q2	ste	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.0278
CY2019Q2	ste	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.0277
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q2	ste	Deferred Ordinary Shares DeferredOrdinaryShares	25000	shares
CY2019Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	78979000	USD
CY2019Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	USD
CY2020Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	333932000	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	35000	shares
CY2020Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	5047000	USD
CY2019Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	60000	shares
CY2019Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8612000	USD
CY2020Q2	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	63150	shares
CY2020Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9248000	USD
CY2019Q2	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	66745	shares
CY2019Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7446000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3554149	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0046
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0227
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0096
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0123
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.2304
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	97.56
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1976104	shares
CY2020Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	96435	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	59.65
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1951	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1796126	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	91.29
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	278364	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	182.22
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	105.64
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102472000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1173669	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	79.79
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	86437000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	772889	shares
CY2020Q2	ste	Common Stock Fair Market Value Per Share CommonStockFairMarketValuePerShare	153.44
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9581000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18843000	USD
CY2020Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5367000	USD
CY2019Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9899000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.44
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.19
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	63875000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-235463000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27937000	USD
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2020Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-828000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	27109000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-208354000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-159778000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3629000	USD
CY2020Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7381000	USD
CY2020Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2234000	USD
CY2020Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2613000	USD
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7002000	USD
CY2020Q2	ste	Nonderivative Net Investment Hedge NonderivativeNetInvestmentHedge	46698000	USD
CY2020Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	309000	USD
CY2019Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-1758000	USD
CY2019Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-695000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2934000	USD
CY2020Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	15976000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	15988000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-156844000	USD
CY2018Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4955000	USD
CY2018Q2	ste	Lineof Credit Providedto Investee LineofCreditProvidedtoInvestee	11000000	USD
CY2020Q2	us-gaap	Notes Receivable Net NotesReceivableNet	7316000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	7084000	USD
CY2017	ste	Interest Rate Period InterestRatePeriod	P15Y
	ste	Interest Rate Period InterestRatePeriod	P4Y

Files In Submission

Name	View Source	Status
0001757898-20-000022-index-headers.html	Edgar Link	pending
0001757898-20-000022-index.html	Edgar Link	pending
0001757898-20-000022.txt	Edgar Link	pending
0001757898-20-000022-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ste-20200630.xsd	Edgar Link	pending
ste-20200630_cal.xml	Edgar Link	unprocessable
ste-20200630_def.xml	Edgar Link	unprocessable
ste-20200630_lab.xml	Edgar Link	unprocessable
ste-20200630_pre.xml	Edgar Link	unprocessable
ste0630202010-q.htm	Edgar Link	pending
ste0630202010-q_htm.xml	Edgar Link	completed
ste06302020ex151.htm	Edgar Link	pending
ste06302020ex311.htm	Edgar Link	pending
ste06302020ex312.htm	Edgar Link	pending
ste06302020ex321.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STE
STERIS plc Stock $ste

2020 Q2 Form 10-Q Financial Statement

#000175789820000022 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE STERIS plc Stock $ste

2020 Q2 Form 10-Q Financial Statement

#000175789820000022 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE
STERIS plc Stock $ste